Although there are some similarities between the way that US and European authorities uphold antibody patents, there are also some important differences.
Monika Rai
Advertisement
Monika Rai is a partner at Mathys & Squire LLP. Her practice focuses on proceedings at the European Patent Office in the field of diagnostics, biopharmaceuticals and biologics and advising on IP due diligence projects.
Articles by Monika Rai
Advertisement
Latest Updated Articles
Patenting Antibodies in EuropeSeptember 1st 2018
Advertisement
Advertisement
Trending on BioPharm International
1
AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform
2
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
3
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
4
The BioPharm Brief: FDA Designations for a Bispecific CAR-T, a BLA for Friedreich’s Ataxia, and Phase 2b MASH Data for Efinopegdutide
5